Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator-Reference-Cited by-同舟云学术

Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator

Published:2014-11-05 Issue:12 Volume:16 Page:1331-1336
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Duncker David¹,Haghikia Arash¹,König Thorben¹,Hohmann Stephan¹,Gutleben Klaus-Jürgen²,Westenfeld Ralf³,Oswald Hanno¹,Klein Helmut⁴,Bauersachs Johann¹,Hilfiker-Kleiner Denise¹,Veltmann Christian¹

Affiliation:

1. Department of Cardiology and Angiology; Hannover Medical School; Carl-Neuberg-Strasse 1 Hannover Germany

2. Department of Cardiology, Heart, and Diabetes Centre North Rhine-Westphalia; Ruhr University Bochum; Bad Oeynhausen Germany

3. Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty; University Düsseldorf; Düsseldorf Germany

4. University of Rochester Medical Centre; Heart Research Follow up Program; Rochester NY USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy;Sliwa;Eur J Heart Fail,2010

2. Favourable outcome after peripartum cardiomyopathy: a ten-year study on peripartum cardiomyopathy in a university hospital;Chee;Singapore Med J,2013

3. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy;Blauwet;Heart,2013

4. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death;Goldberger;Heart Rhythm,2008

5. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society;Zipes;Circulation,2006

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of peripartum cardiomyopathy and recurrence risk;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology;European Journal of Heart Failure;2024-08-08

3. Peripartum cardiomyopathy revisited: Current concepts;Journal of Current Cardiology;2024-05

4. The “arrhythmic” presentation of peripartum cardiomyopathy: case series and critical review of the literature;Frontiers in Cardiovascular Medicine;2024-03-14

5. Diagnosis and Management of Peripartum Cardiomyopathy and Recurrence Risk;2024